Bone Markers and Bone Density Changes in Hyperperparathyroid Dialysis Patients Under Cinacalcet Treatment
Condition: Hyperparathyroidism; Secondary, Renal Interventions: Drug: Cinacalcet Tablets; Drug: calcitriol Sponsors: Min-Sheng General Hospital; Taipei Medical University Shuang Ho Hospital; Taipei Medical University; En Chu Kong Hospital; National Taiwan University; Taichung Tzu Chi Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 19, 2020 Category: Research Source Type: clinical trials